↓ Skip to main content

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer

Overview of attention for article published in Breast Cancer Research, June 2009
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
35 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
Published in
Breast Cancer Research, June 2009
DOI 10.1186/bcr2319
Pubmed ID
Authors

Frank Wiesmann, Jürgen Veeck, Oliver Galm, Arndt Hartmann, Manel Esteller, Ruth Knüchel, Edgar Dahl

Abstract

Endothelin (EDN) signalling plays a crucial role in cell differentiation, proliferation and migration processes. There is compelling evidence that altered EDN signalling is involved in carcinogenesis by modulating cell survival and promoting invasiveness. To date, most reports have focused on the oncogenic potential of EDN1 and EDN2, both of which are overexpressed in various tumour entities. Here, we aimed at a first comprehensive analysis on EDN3 expression and its implication in human breast cancer.

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 26%
Researcher 7 20%
Student > Master 6 17%
Student > Bachelor 2 6%
Professor > Associate Professor 2 6%
Other 8 23%
Unknown 1 3%
Readers by discipline Count As %
Agricultural and Biological Sciences 17 49%
Biochemistry, Genetics and Molecular Biology 6 17%
Medicine and Dentistry 4 11%
Chemistry 2 6%
Physics and Astronomy 2 6%
Other 3 9%
Unknown 1 3%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2010.
All research outputs
#3,819,756
of 12,978,654 outputs
Outputs from Breast Cancer Research
#586
of 1,467 outputs
Outputs of similar age
#80,047
of 277,669 outputs
Outputs of similar age from Breast Cancer Research
#3
of 3 outputs
Altmetric has tracked 12,978,654 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,467 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.